LEVOISOVALERIL SPIRAMYCIN II, PREPARATIONS, METHOD OF PREPARATION AND USE Russian patent published in 2018 - IPC C07H17/08 C12P19/62 A61K31/7048 A61P31/04 A61P31/10 

Abstract RU 2647236 C1

FIELD: pharmaceutical industry.

SUBSTANCE: invention relates to the preparation and use in the pharmaceutical industry of crystalline levoisovaleril spiramycin II of formula (I):

characterized by the melting point of 120–128 °C and X-ray diffraction, measured using Cu-K radiationα with peaks at 2θ = 10.0°, 11.6°, 16.4°, 17.3°, 19.1°, 21.2°, 22.1°, 22.7°, 26.4°, 26.9°, 27.5° and 31.5°, whereby dissolving said crystalline compound in chloroform at 25 °C and a concentration of 0.02 g/ml optical rotation angle [α]D is -55° – 61°. A method for the preparation of said crystalline compound comprises dissolving the solid levoisovaleril spiramycin II in a mixture of absolute methyl alcohol, anhydrous acetone and absolute ethyl alcohol in a ratio of 1: 0.1–10:0.5–1, adding distilled water with stirring, cooling to 5–15 °C to obtain the said crystallographic compound of levoisovaleril spiramycin II.

EFFECT: new effective method of obtaining a new crystalline form is introduced, suitable for the effective preparation of drug anti-infectious agents is proposed.

19 cl, 5 dwg, 56 ex, 10 tbl

Similar patents RU2647236C1

Title Year Author Number
LEVOROTATORY ISOVALERYLSPIRAMYCIN 1, II, III, PREPARATIONS, METHOD FOR PREPARATION AND USE 2011
  • Dzhiang Yang
  • Khao Uyuuou
RU2593498C2
DOSAGE FORM LEVOCARRIMYCIN, METHOD FOR PRODUCTION AND USE THEREOF 2011
  • Jiang Yang
  • Hao Yuyou
RU2593499C2
LEVOYSOVALERIL SPIRAMYCIN III, PREPARATIONS, METHOD OF PREPARATION AND USE 2011
  • Jiang Yang
  • Hao Yuyou
RU2647237C1
RAPAMYCIN TARGET INHIBITOR IN MAMMALIAN CELLS, PHARMACEUTICAL COMPOSITION AND USE THEREOF 2019
  • Ksia, Mingyu
  • Zhao, Ksiaofeng
  • Dzhiang, Ksyunlej
  • Dzhiang, Ksyundong
RU2768583C2
USE OF CARRIMYCIN OR ITS ACTIVE INGREDIENTS 2019
  • Ksia, Mingyu
  • Zhao, Ksiaofeng
  • Dzhiang, Ksyunlej
  • Dzhiang, Ksyundong
RU2771046C2
USE OF ISOVALERYL-SPIRAMYCIN I, II AND/OR III IN MANUFACTURE OF DRUG FOR TREATMENT AND/OR PREVENTION OF TUMOR AND PREPARATION OF DRUG 2018
  • Dzhiang, Enkhong
  • Khe, Vejking
  • Dai, Dzhianlyu
  • Dzhiang, Yang
  • Dzhiang, Ksyunlej
  • Zhao, Ksiaofeng
RU2766176C2
THE USE OF CARRIMYCIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PRODUCTION OF MEDICINES FOR TREATMENT AND / OR TUMOR PREVENTION 2018
  • Dzhiang, Enkhong
  • Ksia, Mingyu
  • Dzhiang, Ksyunlej
  • Dzhiang, Ksyundong
RU2746047C1
BIOSYNTHETIC GENE CLUSTER OF CARRIMYCIN 2016
  • Vang Yuiguang
  • Dzhang Yang
  • Zhao Ksiaofeng
  • Khe Vejking
  • Dai Dzhianlu
RU2719189C2
METHOD FOR USING CARRIMYCIN AGAINST INFECTION RESISTANCE INDUCED BY MYCOBACTERIUM TUBERCULOSIS 2016
  • Vang Yuiguang
  • Dzhang Yang
  • Zhao Ksiaofeng
  • Khao Vejking
RU2733382C2
METHOD OF OBTAINING PENICILLIN DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS (VERSIONS) 0
  • Khirosi Isikava
  • Fudzio Tabusa
  • Kazuyuki Nakagava
SU1151212A3

RU 2 647 236 C1

Authors

Jiang Yang

Hao Yuyou

Dates

2018-03-14Published

2011-05-25Filed